Table 2 Specificity of IgG antibodies for block 4 allelic forms in each study population and in all study populationsa
From: Shift in epitope dominance of IgM and IgG responses to Plasmodium falciparum MSP1 block 4
Block 4 Peptide(s) | Colombia | Papua New Guinea | Cameroon | Total |
|---|---|---|---|---|
1 | 9% | 20% | 9% | 13% |
2 | 68 | 15 | 27 | 40 |
3 | 9 | 0 | 0 | 6 |
4 | 4.5 | 0 | 27 | 7 |
1+2 | 4.5 | 5 | 0 | 4 |
1+3 | 0 | 5 | 0 | 2 |
1+4 | 0 | 5 | 9 | 4 |
2+3 | 0 | 0 | 0 | 0 |
2+4 | 4.5 | 10 | 9 | 7 |
3+4 | 0 | 0 | 0 | 0 |
1+2+3 | 0 | 10 | 9 | 6 |
1+2+4 | 0 | 10 | 9 | 6 |
1+3+4 | 0 | 0 | 0 | 0 |
2+3+4 | 0 | 5 | 0 | 2 |
1+2+3+4 | 0 | 15 | 0 | 6 |